Iridex share price today

(IRIX)

Iridex share price is $1.83 & ₹156.90 as on 3 Jan 2025, 2.30 'hrs' IST

$1.83

▲

0.15

(8.93%)

Market is closed - opens 8 PM, 03 Jan 2025

View live Iridex share price in Dollar and Rupees. Guide to invest in Iridex from India. Also see the sentimental analysis on Indian investors investing in Iridex. Get details on the Indian mutual funds that are investing in Iridex. Get Analyst recommendations and forecasts along with all the Iridex's financials.

Iridex share price movements

Today's Low: $1.68
Today's High: $1.87
$1.83
8.2%
Downside
Day's Volatility :10.31%
Upside
2.31%
52 Weeks Low: $1.27
52 Weeks High: $3.65
$1.83
30.51%
Downside
52 Weeks Volatility :65.16%
Upside
49.86%

Iridex Returns

Period	Iridex Corp	Index (Russel 2000)
3 Months	-0.59%	0.0%
6 Months	-18.84%	0.0%
1 Year	-41.87%	0.0%
3 Years	-72.5%	-21.2%

Iridex Key Statistics

in dollars & INR

Previous Close	$1.68
Open	$1.68
Today's High	$1.8732
Today's Low	$1.68
Market Capitalization	$27.9M
Today's Volume	$78.9K
52 Week High	$3.65
52 Week Low	$1.2717
Revenue TTM	$48.4M
EBITDA	$-10.1M
Earnings Per Share (EPS)	$-0.67
Profit Margin	-22.79%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-150.28%

How to invest in Iridex from India?

It is very easy for Indian residents to invest directly in Iridex from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Iridex stock in both Indian Rupees (INR) and US Dollars (USD). Search for Iridex or IRIX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Iridex or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Iridex shares which would translate to 0.469 fractional shares of Iridex as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Iridex, in just a few clicks!

Returns in Iridex for Indian investors in Rupees

Investment Value

₹1,00,000

Iridex investment value today

Current value as on today

₹66,297

Returns

₹33,703

(-33.7%)

Returns from Iridex Stock

₹36,678 (-36.68%)

Dollar Returns

₹2,975 (+2.97%)

Indian investors sentiment towards Iridex

-68%

Period: Oct 4, 2024 to Jan 2, 2025. Change in 30 Days versus previous period

Search volume for Iridex on INDmoney from India has reduced in the last 30 days as on Jan 3, 2025. -68% less investors are searching Iridex in the last 30 days versus the previous period.

Global Institutional Holdings in Iridex

PARAGON Assoc & PARAGON Assoc II JV
6.01%
Vanguard Group Inc
3.37%
AMH Equity Ltd
3.01%
Renaissance Technologies Corp
2.39%
Geode Capital Management, LLC
0.79%
Schmeidler A R & CO Inc
0.68%

Analyst Recommendation on Iridex

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Iridex(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Iridex

What analysts predicted

Upside of 9.29%

Current:

$1.83

Target:

$2.00

Insights on Iridex

Price Movement
In the last 1 year, IRIX stock has moved down by -41.5%
Decreasing Revenue
Revenue is down for the last 2 quarters, 12.63M → 11.58M (in $), with an average decrease of 8.3% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -3.46M → -1.93M (in $), with an average increase of 34.0% per quarter
IRIX vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 54.4% return, outperforming this stock by 95.9%
IRIX vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 110.3% return, outperforming this stock by 182.8%
Price to Sales
ForIRIX every $1 of sales, investors are willing to pay $0.6, whereas for Boston Scientific Corp., the investors are paying $8.2 for every $1 of sales.

Iridex Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$42.6M	↑ 2.42%
Net Income	$-12.8M	↓ 0.42%
Net Profit Margin	-30.08%	↑ 0.86%

	FY19	Y/Y Change
Revenue	$43.4M	↑ 1.99%
Net Income	$-8.8M	↓ 31.22%
Net Profit Margin	-20.28%	↑ 9.8%

	FY20	Y/Y Change
Revenue	$36.3M	↓ 16.34%
Net Income	$-6.3M	↓ 28.19%
Net Profit Margin	-17.41%	↑ 2.87%

	FY21	Y/Y Change
Revenue	$53.9M	↑ 48.3%
Net Income	$-5.2M	↓ 17.44%
Net Profit Margin	-9.69%	↑ 7.72%

	FY22	Y/Y Change
Revenue	$57.0M	↑ 5.69%
Net Income	$-7.5M	↑ 44.44%
Net Profit Margin	-13.25%	↓ 3.56%

	FY23	Y/Y Change
Revenue	$51.9M	↓ 8.96%
Net Income	$-9.6M	↑ 26.81%
Net Profit Margin	-18.45%	↓ 5.2%

	Q2 FY23	Q/Q Change
Revenue	$12.9M	↓ 6.21%
Net Income	$-2.8M	↑ 32.34%
Net Profit Margin	-21.52%	↓ 6.27%

	Q3 FY23	Q/Q Change
Revenue	$12.9M	↓ 0.04%
Net Income	$-1.8M	↓ 36.59%
Net Profit Margin	-13.65%	↑ 7.87%

	Q4 FY23	Q/Q Change
Revenue	$12.5M	↓ 3.05%
Net Income	$-3.0M	↑ 68.76%
Net Profit Margin	-23.76%	↓ 10.11%

	Q1 FY24	Q/Q Change
Revenue	$11.8M	↓ 5.59%
Net Income	$-3.5M	↑ 17.03%
Net Profit Margin	-29.45%	↓ 5.69%

	Q2 FY24	Q/Q Change
Revenue	$12.6M	↑ 7.4%
Net Income	$-2.7M	↓ 22.66%
Net Profit Margin	-21.21%	↑ 8.24%

	Q3 FY24	Q/Q Change
Revenue	$11.6M	↓ 8.31%
Net Income	$-1.9M	↓ 27.85%
Net Profit Margin	-16.69%	↑ 4.52%

	FY18	Y/Y Change
Profit	$17.5M	↑ 12.69%

	FY19	Y/Y Change
Profit	$17.9M	↑ 2.68%

	FY20	Y/Y Change
Profit	$15.6M	↓ 13.27%

	FY21	Y/Y Change
Profit	$22.8M	↑ 46.75%

	FY22	Y/Y Change
Profit	$25.4M	↑ 11.11%

	FY23	Y/Y Change
Profit	$21.8M	↓ 14.04%

	Q2 FY23	Q/Q Change
Profit	$5.4M	↓ 9.68%

	Q3 FY23	Q/Q Change
Profit	$5.6M	↑ 4.81%

	Q4 FY23	Q/Q Change
Profit	$4.8M	↓ 14.55%

	Q1 FY24	Q/Q Change
Profit	$4.4M	↓ 8.93%

	Q2 FY24	Q/Q Change
Profit	$5.1M	↑ 15.5%

	Q3 FY24	Q/Q Change
Profit	$4.3M	↓ 14.43%

	FY18	Y/Y Change
Operating Cash Flow	$-10.0M	↑ 181.21%
Investing Cash Flow	$-827.0K	↑ 5.75%
Financing Cash Flow	$10.4M	↑ 349.89%

	FY19	Y/Y Change
Operating Cash Flow	$-7.9M	↓ 21.07%
Investing Cash Flow	$-509.0K	↓ 38.45%
Financing Cash Flow	$-156.0K	↓ 101.5%

	FY20	Y/Y Change
Operating Cash Flow	$-3.2M	↓ 59.09%
Investing Cash Flow	$-93.0K	↓ 81.73%
Financing Cash Flow	$2.5M	↓ 1681.41%

	FY21	Y/Y Change
Operating Cash Flow	$8.2M	↓ 353.85%
Investing Cash Flow	$-5.6M	↑ 5874.19%
Financing Cash Flow	$9.5M	↑ 283.7%

	FY22	Y/Y Change
Operating Cash Flow	$-9.5M	↓ 215.85%
Investing Cash Flow	$-286.0K	↓ 94.85%
Financing Cash Flow	$-73.0K	↓ 100.77%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-1.1M	↓ 59.87%
Investing Cash Flow	$-16.0K	↓ 62.79%
Financing Cash Flow	$-63.0K	↓ 270.27%

Iridex Technicals Summary

Sell

Neutral

Buy

Iridex is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Iridex Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Iridex Corp	-10.64%	-18.84%	-41.87%	-72.5%	-24.66%
Stryker Corporation	-7.91%	6.76%	20.8%	29.62%	69.66%
Boston Scientific Corp.	-1.27%	16.91%	53.55%	104.67%	96.96%
Edwards Lifesciences Corp.	5.46%	-19.81%	0.69%	-42.11%	-5.41%
Abbott Laboratories	-2.73%	8.74%	1.92%	-16.69%	31.01%
Medtronic Plc	-6.8%	2.92%	-4.83%	-24.92%	-30.47%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Iridex Corp	NA	NA	-0.44	0.0	-1.5	-0.21	NA	0.16
Stryker Corporation	38.59	38.59	2.51	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.82	73.82	1.63	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.58	28.58	6.8	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.38	34.38	2.19	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.35	24.35	1.45	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Iridex Corp	Sell	$27.9M	-24.66%	NA	-22.79%
Stryker Corporation	Buy	$137.3B	69.66%	38.59	16.34%
Boston Scientific Corp.	Buy	$131.6B	96.96%	73.82	11.26%
Edwards Lifesciences Corp.	Buy	$43.7B	-5.41%	28.58	65.86%
Abbott Laboratories	Buy	$196.2B	31.01%	34.38	13.99%
Medtronic Plc	Buy	$102.1B	-30.47%	24.35	12.06%

About Iridex

iridex corporation, founded in 1989, is a worldwide leader in developing, manufacturing, and marketing innovative and versatile light-based medical systems and delivery devices. we offer laser based solutions for multiple specialties including aesthetic medicine, ophthalmology, and otolaryngology. we also maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. with superior technology for superior results, iridex is dedicated to standards of excellence that meet your own.

Organization	Iridex
Employees	111
CEO	Mr. Scott A. Shuda J.D.
Industry	Health Technology

Management People of Iridex

Name	Title
Mr. Scott A. Shuda J.D.	Executive Chairman
Mr. Patrick Mercer	CEO & President
Mr. Fuad Ahmad	Interim Chief Financial Officer
Ms. Leigh Salvo	Head of Investor Relations

Important FAQs about investing in Iridex from India :

What is Iridex share price today?

Iridex share price today stands at $1.83, Open: $1.68 ; Previous Close: $1.68 ; High: $1.87 ; Low: $1.68 ; 52 Week High: $3.65 ; 52 Week Low: $1.27. The stock opens at $1.68, after a previous close of $1.68. The stock reached a daily high of $1.87 and a low of $1.68, with a 52-week high of $3.65 and a 52-week low of $1.27.

Can Indians buy Iridex shares?

Yes, Indians can invest in the Iridex (IRIX) from India.

With INDmoney, you can buy Iridex at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Iridex at zero transaction cost.

How can I buy Iridex shares from India?

It is very easy to buy Iridex from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Iridex be purchased?

Yes, you can buy fractional shares of Iridex with INDmoney app.

What are the documents required to start investing in Iridex stocks?

To start investing in Iridex, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.